Diminished Ovarian Reserve: Causes, Symptoms, AMH Levels and Fertility Options

Being told that you have diminished ovarian reserve (DOR) can raise many questions.

Does it mean that you are running out of eggs? Can you still become pregnant naturally? Does low ovarian reserve mean poor egg quality? Can IVF work with diminished ovarian reserve? And is there anything you can do to improve your fertility?

The most important point to understand is that diminished ovarian reserve does not automatically mean infertility.

Ovarian reserve primarily describes the number of eggs remaining in the ovaries. It provides valuable information about how the ovaries may respond to fertility treatment, particularly ovarian stimulation during IVF, but it cannot independently determine whether a woman can become pregnant.

Age, egg quality, sperm quality, ovulation, uterine health and previous reproductive history all contribute to fertility.

Understanding DOR in the context of your complete reproductive profile is therefore essential when deciding what to do next.

What Is Diminished Ovarian Reserve?

Diminished Ovarian Reserve (DOR) refers to a reduction in the number of oocytes—or eggs—remaining in the ovaries compared with what might be expected at a particular stage of reproductive life.

Ovarian reserve naturally declines as women become older. However, some women experience a lower ovarian reserve at a younger age than expected.

Women with DOR may still have regular menstrual cycles and continue to ovulate.

The condition becomes particularly relevant during fertility treatment because women with diminished ovarian reserve may produce fewer follicles and eggs in response to ovarian stimulation.

This distinction is important:

Diminished ovarian reserve describes primarily egg quantity. It does not directly measure egg quality.

What Happens to Ovarian Reserve as We Age?

Women are born with a finite supply of oocytes.

This pool gradually declines throughout life through natural biological processes. Unlike many other cells in the body, the conventional understanding of human reproductive biology is that this ovarian reserve is not naturally replenished.

Consequently, declining ovarian reserve is a normal part of reproductive aging.

However, the rate of decline varies significantly between women.

Two women of exactly the same age may therefore have very different ovarian reserves.

This is why chronological age and ovarian reserve testing provide related but different information when assessing fertility.

What Causes Diminished Ovarian Reserve?

Age is the most common factor associated with declining ovarian reserve.

However, diminished ovarian reserve can also occur in younger women.

Potential risk factors or associated conditions may include:

• Increasing reproductive age
• Genetic factors
• Family history of early menopause
• Previous ovarian surgery
• Endometriosis
• Chemotherapy
• Radiotherapy
• Certain autoimmune or medical conditions
• Genetic or chromosomal abnormalities
• Smoking and other environmental exposures

In some women, no specific cause can be identified.

This is sometimes referred to as idiopathic diminished ovarian reserve.

Whatever the cause, identifying reduced ovarian reserve early can provide valuable information when planning pregnancy, fertility preservation or assisted reproductive treatment.

Are There Symptoms of Diminished Ovarian Reserve?

One of the challenges with DOR is that there may be no obvious symptoms.

Many women continue to have regular menstrual periods and do not realize that their ovarian reserve is reduced until they undergo fertility testing.

Others may discover DOR after experiencing difficulty conceiving or after responding poorly to ovarian stimulation during an IVF cycle.

In more advanced cases of declining ovarian function, changes in menstrual cycles may occur.

However, symptoms alone cannot reliably diagnose diminished ovarian reserve.

Laboratory testing, ultrasound evaluation and clinical history are required to understand the complete picture.

Is Diminished Ovarian Reserve the Same as Premature Ovarian Insufficiency?

No.

Although the terms are sometimes confused, diminished ovarian reserve (DOR) and premature ovarian insufficiency (POI) are not identical.

A woman with diminished ovarian reserve may continue to ovulate and have regular menstrual cycles, although fewer follicles may be available and the response to fertility medication may be reduced.

Premature ovarian insufficiency involves loss or substantial impairment of normal ovarian activity before age 40 and requires its own diagnostic evaluation and management.

Distinguishing between the two conditions is important because their reproductive and wider health implications can differ.

How Is Diminished Ovarian Reserve Diagnosed?

There is no single test that can describe every aspect of ovarian function.

A fertility specialist therefore evaluates several pieces of information together.

The most commonly used ovarian reserve markers include:

• Anti-Müllerian Hormone (AMH)
• Antral Follicle Count (AFC)
• Follicle-Stimulating Hormone (FSH)
• Estradiol (E2)

Age, menstrual history, previous ovarian surgery, previous pregnancies and previous response to fertility medication may also provide important information.

For women who have previously undergone IVF, the actual number of follicles developed and eggs retrieved can be particularly informative.

AMH and Diminished Ovarian Reserve

Anti-Müllerian Hormone (AMH) is one of the most widely used markers of ovarian reserve.

AMH is produced by cells associated with small developing follicles within the ovaries.

Generally, lower AMH concentrations are associated with a lower number of available follicles and may predict a reduced response to ovarian stimulation.

AMH is particularly useful when planning IVF because it can help the fertility team estimate how the ovaries might respond to medication.

However, AMH has limitations.

A low AMH result does not mean that there are no eggs remaining, and it does not automatically mean that natural pregnancy or IVF pregnancy is impossible.

Most importantly:

AMH does not directly measure the quality of the remaining eggs.

What Is Antral Follicle Count?

Antral Follicle Count (AFC) is another important measure of ovarian reserve.

During a transvaginal ultrasound, the fertility specialist counts the small follicles visible within the ovaries during the appropriate phase of the menstrual cycle.

A lower AFC may indicate diminished ovarian reserve and can help predict the expected response to ovarian stimulation.

AMH and AFC are therefore frequently considered together when planning fertility treatment.

Neither test, however, should be interpreted without considering the woman’s age and broader reproductive circumstances.

What Do FSH and Estradiol Tell Us?

Follicle-Stimulating Hormone (FSH) plays an important role in stimulating follicular development.

Basal FSH and estradiol are generally assessed during the early follicular phase of the menstrual cycle.

An elevated FSH level can be associated with diminished ovarian reserve, although FSH can vary between menstrual cycles.

Estradiol is commonly interpreted alongside FSH because an elevated early-cycle estradiol level may affect how the FSH result is interpreted.

These tests can provide useful additional information, but—as with AMH—they should form part of a broader fertility assessment rather than being viewed as isolated fertility scores.

Does Diminished Ovarian Reserve Mean Poor Egg Quality?

Not necessarily.

This is one of the most important misconceptions about ovarian reserve.

Egg quantity and egg quality are different concepts.

DOR primarily describes a reduction in the number of available eggs.

Egg quality, particularly the probability that an egg has normal chromosomal potential, is much more strongly associated with female age.

A younger woman with diminished ovarian reserve may therefore have fewer eggs available but should not automatically assume that the eggs she has are poor quality.

Conversely, an older woman may have a relatively reassuring AMH but still experience age-related changes in egg quality.

This is why age remains fundamental when interpreting ovarian reserve.

Can You Get Pregnant Naturally with Diminished Ovarian Reserve?

Yes, natural pregnancy can still occur.

A diagnosis of DOR does not mean that a woman has stopped ovulating or that the remaining eggs cannot be fertilized.

Ovarian reserve tests are much more useful for predicting response to ovarian stimulation than for predicting whether an individual woman will conceive naturally.

Natural conception also depends on:

• Age
• Ovulation
• Egg quality
• Fallopian tube function
• Sperm quality
• Timing of intercourse
• Uterine health
• Other female and male fertility factors

A diagnosis of diminished ovarian reserve should therefore lead to appropriate fertility counseling rather than an assumption that natural conception is impossible.

Diminished Ovarian Reserve and IVF

DOR becomes particularly relevant during in vitro fertilization (IVF).

During IVF, fertility medication is used to stimulate the development of multiple follicles.

Women with diminished ovarian reserve may develop fewer follicles and consequently produce fewer eggs during retrieval.

This can reduce the number of eggs available for fertilization and the number of embryos potentially available for transfer or cryopreservation.

However, a lower number of eggs does not mean that IVF cannot work.

Treatment decisions should take into account age, previous ovarian response, egg and embryo development, sperm quality and the woman’s complete fertility history.

Even extremely low AMH should not, by itself, be used to conclude that IVF treatment is futile.

Can IVF Treatment Be Personalized for DOR?

Yes.

Women with diminished ovarian reserve frequently require an individualized ovarian stimulation strategy.

Treatment planning may consider:

• Age
• AMH
• AFC
• Basal FSH and estradiol
• Previous ovarian stimulation
• Number of eggs previously retrieved
• Previous fertilization and embryo development
• Other causes of infertility

There is no single stimulation protocol that is ideal for every woman with DOR.

More medication also does not necessarily mean more eggs.

The objective is to develop a treatment strategy appropriate for the patient’s remaining ovarian reserve and previous response.

Does ICSI Improve IVF Success in Women with DOR?

Intracytoplasmic Sperm Injection (ICSI) involves injecting a single sperm directly into an egg.

ICSI is an important technique for certain forms of male-factor infertility and other selected indications.

However, diminished ovarian reserve by itself does not necessarily mean that ICSI will improve IVF outcomes.

The decision to use conventional IVF fertilization or ICSI should therefore be based on the couple’s complete fertility profile rather than ovarian reserve alone.

Can Diminished Ovarian Reserve Be Reversed?

Currently, there is no established treatment that can reliably restore the natural ovarian reserve or replace the eggs that have been lost through reproductive aging.

This is an important distinction because women with DOR are frequently exposed to treatments or supplements claiming to “increase ovarian reserve.”

A laboratory AMH value can sometimes change between measurements, but a change in AMH should not automatically be interpreted as evidence that new eggs have been created.

The goal of fertility management is therefore not simply to increase AMH.

The more clinically meaningful objective is to understand the reproductive potential that remains and determine how best to use it.

Can Lifestyle Help with Diminished Ovarian Reserve?

Lifestyle cannot restore the natural egg supply.

However, general health can influence reproductive wellbeing and preparation for pregnancy or fertility treatment.

A fertility optimization strategy may include:

• Avoiding smoking
• Maintaining an appropriate body weight
• Following a balanced diet
• Correcting identified nutritional deficiencies
• Maintaining appropriate physical activity
• Getting adequate sleep
• Managing underlying medical conditions
• Reviewing medications and supplements with the fertility team

These measures should be viewed as supportive strategies rather than treatments capable of reversing diminished ovarian reserve.

What About Supplements for Low Ovarian Reserve?

Vitamins, antioxidants and fertility supplements are frequently marketed to women with low AMH or DOR.

Some nutrients and supplements have been investigated for reproductive health, but evidence varies considerably.

No supplement should be presented as a proven method of creating new eggs or restoring ovarian reserve.

Supplementation is best individualized according to nutritional status, medical history and fertility treatment.

This is especially important because women with DOR may have a limited reproductive window, and delaying appropriate fertility treatment while attempting to increase AMH through supplements may not be beneficial.

Fertility Preparation Before IVF

For women with diminished ovarian reserve preparing for IVF, a comprehensive strategy may include evaluation of nutritional, metabolic and general health alongside conventional reproductive assessment.

At Chania Fertility Unit, individualized fertility preparation may be considered according to each woman’s reproductive profile.

This can include nutritional assessment and, for selected patients, supportive approaches such as Ovarian Boost IV Therapy as part of a broader fertility preparation program.

The objective is to support nutritional adequacy, antioxidant defenses and general metabolic health.

Such interventions should be viewed as supportive care and not as treatments proven to restore ovarian reserve or guarantee improved IVF outcomes.

What Is Ovarian Rejuvenation?

Ovarian rejuvenation is an emerging area of regenerative reproductive medicine that investigates whether regenerative biological approaches may influence ovarian tissue, cellular signaling and the ovarian microenvironment.

Approaches currently being explored include:

• Ovarian Platelet-Rich Plasma (PRP)
• Enriched PRP (EnPRP)
• Exosome therapy
• Stem-cell-related regenerative approaches

PRP, for example, uses a preparation derived from the patient’s own blood containing concentrated platelets and associated growth factors.

Researchers have investigated whether these biological signals could influence aspects of ovarian tissue function.

Exosomes and stem-cell-related approaches are also being studied within the broader field of regenerative medicine.

Can Ovarian Rejuvenation Restore Ovarian Reserve?

This question requires particular caution.

Ovarian rejuvenation therapies are emerging and investigational. They are not currently established methods for creating new eggs, reversing ovarian aging or reliably restoring ovarian reserve.

Research continues to investigate their potential role in women with diminished ovarian reserve and poor ovarian response.

Any patient considering regenerative treatment should therefore understand both its theoretical rationale and the limitations of the current evidence.

At Chania Fertility Unit, regenerative approaches can be considered for selected patients within a personalized fertility strategy, following evaluation of age, ovarian reserve, reproductive history and previous treatment outcomes.

They should not replace established fertility treatments when those treatments are indicated.

Should You Consider Egg Freezing?

For women who are not currently ready to attempt pregnancy, fertility preservation may be worth discussing.

Egg freezing (oocyte cryopreservation) allows mature eggs retrieved during ovarian stimulation to be stored for possible future use.

However, both age and ovarian reserve influence the number of eggs that may be obtained.

Women with DOR may require realistic counseling regarding expected egg yield and whether more than one stimulation cycle might be considered.

Because age affects the reproductive potential of eggs, earlier fertility-preservation discussions can be valuable for women at increased risk of declining ovarian function.

When Should You See a Fertility Specialist?

Consider seeking fertility advice if:

• You have been diagnosed with low AMH or diminished ovarian reserve
• Your AFC is lower than expected
• You have experienced a poor response during previous IVF treatment
• You have had ovarian surgery
• You have endometriosis
• You have received chemotherapy or radiotherapy
• You have a family history of early menopause
• Your menstrual cycles have become irregular
• You are 35 or older and have been trying to conceive without success
• You are over 40 and wish to become pregnant
• You are considering fertility preservation

For women with known risk factors for diminished ovarian reserve, fertility assessment may be appropriate without waiting for the usual period of attempting natural conception.

Diminished Ovarian Reserve: Focus on the Complete Fertility Picture

A diagnosis of diminished ovarian reserve can be concerning, but it should not be viewed as a definitive prediction of infertility.

DOR primarily tells us that the number of available eggs—and potentially the expected response to ovarian stimulation—is reduced.

It does not tell us with certainty whether pregnancy can occur.

Age, egg quality, sperm quality, uterine health, previous fertility treatment and other reproductive factors all need to be considered.

Most importantly, women with diminished ovarian reserve should avoid focusing exclusively on raising AMH.

The objective is to understand the reproductive potential available now and develop an individualized strategy without unnecessary delay.

At Chania Fertility Unit, women with diminished ovarian reserve can undergo comprehensive assessment of ovarian function and fertility potential, allowing the medical team to develop an individualized treatment plan that may include assisted reproductive technologies, fertility preparation and, for appropriately selected patients, discussion of emerging regenerative fertility approaches.